1990-2017年全球、区域及国家层面卵巢癌的发病与死亡情况
该研究从全球疾病负担数据库提取卵巢癌年龄标化发病率和死亡率,用估计平均年度变化百分比量化1990-2017年趋势。全球发病与死亡例数增加,但年龄标化发病率和死亡率略降;发达国家下降明显,而超过三分之二国家出现上升,提示发展中国家卵巢癌诊断将更常见。
要点
- 全球年龄标化发病率和死亡率略降,EAPC分别为-0.10(95%CI -0.16至-0.03)和-0.32(95%CI -0.38至-0.27)。
- 年龄标化发病率上升、稳定、下降的国家或地区分别为137、10、48个;死亡率分别为129、9、57个。
核心结论
- 发达国家卵巢癌发病率和死亡率显著下降,但超过三分之二国家出现明显上升,提示发展中国家卵巢癌诊断将更常见。
研究设计与样本
- 基于全球疾病负担研究在线数据库的数据库分析,提取卵巢癌年龄标化发病率和死亡率,用估计平均年度变化百分比量化1990-2017年趋势。
主要发现
- 全球年龄标化发病率EAPC为-0.10(95%CI -0.16至-0.03),年龄标化死亡率EAPC为-0.32(95%CI -0.38至-0.27)。
- 西欧年龄标化发病率和死亡率下降幅度最大,EAPC分别为-1.22(95%CI -1.31至-1.14)和-1.31(95%CI -1.37至-1.25)。
- 1990-2017年间,137个国家或地区年龄标化发病率上升、10个稳定、48个下降;129个国家或地区年龄标化死亡率上升、9个稳定、57个下降。
- 年龄标化发病率和死亡率上升幅度最大见于加勒比和拉丁美洲国家。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Ovarian cancer (OC) is a commonly diagnosed gynecologic cancer. Knowing the incidence and mortality rates of OC is critical to understanding the disease burden and updating prevention strategies. METHODS: We retrieved the age-standardized incidence and mortality rates (ASIR and ASMR, respectively) of OC from the Global Burden of Disease study online database. Estimated average percentage change (EAPC) was used to quantify the trends of OC incidence and mortality from 1990 to 2017. RESULTS: Worldwide, the number of incident cases and deaths from OC increased from 152.1 and 95.5 thousand in 1990 to 286.1 and 176.0 thousand in 2017, respectively. Both the ASIR and ASMR decreased slightly during the study period (EAPC = -0.10, 95% CI, -0.16, -0.03; EAPC = -0.32, 95% CI, -0.38, -0.27). The greatest decreases of ASIR and ASMR were observed in Western Europe (EAPC = -1.22, 95% CI, -1.31, -1.14; EAPC = -1.31, 95% CI, -1.37, -1.25). A total of 137, 10, and 48 countries or territories experienced an increase, remained stable, and experienced a decrease in OC ASIR, respectively, between 1990 and 2017. For ASMR, a total of 129, 9, and 57 countries or territories experienced an increase, remained stable, and experienced a decrease, respectively, during the same period. The greatest increases in the ASIR and the ASMR were found in countries located in the Caribbean and Latin America. CONCLUSIONS: The incidence and mortality of OC significantly decreased in developed countries. However, remarkable increases were observed in more than two-thirds of all countries, suggesting that OC will be more frequently diagnosed in developing countries.
引用
- Zheng L, Cui C, Shi O, et al. Incidence and mortality of ovarian cancer at the global, regional, and national levels, 1990-2017. Gynecol Oncol. 2020. PMID: 32690392. doi:10.1016/j.ygyno.2020.07.008
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。